Gliclazide is a synthetic oral antidiabetic medication used to stimulate insulin secretion in people with type 2 diabetes. It belongs to the sulfonylurea class and is typically prescribed as part of a broader treatment plan including diet and exercise. The word itself comes from a chemical nomenclature tradition and is primarily encountered in medical contexts, research, and pharmacology literature.
Full pronunciation guide